News
Deadly brain tumor: Survival extended by oncolytic virus product
Improved survival was seen in a small trial in which a genetically engineered version of herpes simplex virus was infused directly into high-grade...
News
Combo shows efficacy in platinum-resistant ovarian cancer
Ixabepilone plus bevacizumab improved outcomes, compared with ixabepilone alone.
News
Niraparib maintenance offers continued benefit in some with recurrent ovarian cancer
Benefits were seen in patients with germline BRCA mutations.
News
Biomarkers predict efficacy of DKN-01 in endometrial cancer
High levels of DKK1 expression and the presence of Wnt or PIK3CA activating mutations are associated with better outcomes.
News
Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costs
The Affordable Care Act did not spare many gynecologic cancer patients from financial hardship.
News
Rucaparib extends PFS in BRCA-mutated ovarian cancer, with an exception
The PARP inhibitor was superior to chemotherapy, except in patients with BRCA reversion mutations.
